Covista Inc. (CVSA)
NYSE:CVSA
Want to see CVSA full AI Analyst Report?
CVSA Stock Chart & Stats
$117.91
-$0.04(-0.04%)
At close: 4:00 PM EST
$117.91
-$0.04(-0.04%)
Day’s Range― - ―
52-Week Range$86.97 - $156.26
Previous CloseN/A
VolumeN/A
Average Volume (3M)303.44K
Market Cap
$4.29B
Enterprise Value$4.88B
Total Cash (Recent Filing)$148.84M
Total Debt (Recent Filing)$736.29M
Price to Earnings (P/E)17.0
Beta0.66
Next Earnings
Aug 06, 2026EPS Estimate
1.94Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.02
Shares Outstanding34,030,888
10 Day Avg. Volume337,162
30 Day Avg. Volume303,440
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)3.29
Price to Sales (P/S)2.64
P/FCF Ratio16.41
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue2.55
Enterprise Value/Gross Profit4.46
Enterprise Value/Ebitda11.30
Forecast
1Y Price Target
$156.25Price Target Upside32.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)7.99
Revenue Forecast (FY)$1.93B
Bulls Say, Bears Say
Bulls Say
AI-enabled Student LifecycleDeployment of AI across the student lifecycle, including AI-assisted enrollment, predictive analytics, persistence-enhancing micro-grants, and an AI tutor integrated into coursework, could boost enrollment conversion and student retention while differentiating the learning experience.
Financing Access And Marketing EfficiencyExisting financing partnerships that increase student access to funding, together with noted improvements in marketing efficiency and enrollment funnel conversion at key brands, can reduce barriers to enrollment and support revenue growth.
Healthcare Program Focus And Employer IntegrationStrategic emphasis on nursing, medical and veterinary programs combined with employer integration initiatives that build contracted pipelines to healthcare systems can strengthen placement outcomes and capture demand driven by workforce shortages.
Bears Say
Aggressive Risk Profile And Investor VolatilityAnalyst classification of the company's suitability as aggressive signals higher investment risk and the potential for greater share-price volatility and downside during operational setbacks.
Brand Performance Concentration RiskUneven performance across brands, where stronger results at one brand have been needed to offset weakness at another, raises reliance on a subset of programs and increases volatility in consolidated results.
Enrollment Funnel Weakness At A Major BrandEnrollment funnel challenges and slowing trends at a major brand, including declines in some post-licensure nursing programs, could weigh on near-term enrollment and revenue performance.
Covista News
CVSA FAQ
What was Covista Inc.’s price range in the past 12 months?
Covista Inc. lowest stock price was $86.97 and its highest was $156.26 in the past 12 months.
What is Covista Inc.’s market cap?
Covista Inc.’s market cap is $4.29B.
When is Covista Inc.’s upcoming earnings report date?
Covista Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 77 days.
How were Covista Inc.’s earnings last quarter?
Covista Inc. released its earnings results on May 07, 2026. The company reported $1.98 earnings per share for the quarter, beating the consensus estimate of $1.722 by $0.258.
Is Covista Inc. overvalued?
According to Wall Street analysts Covista Inc.’s price is currently Undervalued.
Does Covista Inc. pay dividends?
Covista Inc. pays a Semiannually dividend of $0.18 which represents an annual dividend yield of N/A. See more information on Covista Inc. dividends here
What is Covista Inc.’s EPS estimate?
Covista Inc.’s EPS estimate is 1.94.
How many shares outstanding does Covista Inc. have?
Covista Inc. has 34,030,888 shares outstanding.
What happened to Covista Inc.’s price movement after its last earnings report?
Covista Inc. reported an EPS of $1.98 in its last earnings report, beating expectations of $1.722. Following the earnings report the stock price went up 14.299%.
Which hedge fund is a major shareholder of Covista Inc.?
Currently, no hedge funds are holding shares in CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$156.25 (32.52% Upside)
$156.25 (32.52% Upside)
Blogger Sentiment
Bullish
CVSA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 307.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.8%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.45%
12-Months-Change
Fundamentals
Return on Equity
17.78%
Trailing 12-Months
Asset Growth
-1.88%
Trailing 12-Months
Company Description
Covista Inc.
Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.
CVSA Company Deck
CVSA Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: enrollment growth across institutions, improved margins (when adjusting for a one-week timing shift), raised revenue and EPS guidance, robust free cash flow, balance sheet improvement, share repurchases, campus expansion plans, and technology/AI initiatives. Near-term headwinds include an $18M timing impact at Walden that masked stronger underlying results, modest absolute enrollment improvement at Chamberlain this quarter (0.5%), continued investment-driven CapEx and strategic spending, and an expected higher effective tax rate. Overall, the positives (organic growth, margin expansion excluding timing, raised guidance, cash generation, and clear remediation at Chamberlain) outweigh the transitory and execution-related challenges noted.View all CVSA earnings summariesCVSA Stock 12 Month Forecast
Average Price Target
$156.25
▲(32.52% Upside)
Technical Analysis
Perdoceo Education
―
Grand Canyon Education
―
Strategic Education
―
Graham Holdings
―
Laureate Education
―
Ownership Overview
2.76% Insiders
38.73% Mutual Funds
22.29% Other Institutional Investors
8.53% Public Companies and
Individual Investors